Skip to main content

Table 3 Multivariate analysis of prognostic factors for EOC patients (PFS & OS)

From: Acylglycerol kinase promotes ovarian cancer progression and regulates mitochondria function by interacting with ribosomal protein L39

Outcomes Variable HR P 95%CI
PFS The volume of ascites 0.645 0.863 0.462–1.613
Peritoneal cytology 1.535 0.135 0.875–2.694
FIGO stage 2.359 0.008 1.255–4.435
AGK expression 1.726 0.050 1.000–2.981
Outcomes Variable HR P 95%CI
OS The volume of ascites 0.864 0.649 0.461–1.619
Peritoneal cytology 1.538 0.133 0.877–2.695
FIGO stage 2.268 0.011 1.211–4.246
AGK expression 1.802 0.036 1.038–3.127
  1. Abbreviations: LVSI Lymphovascular space invasion, CI Confident interval, HR Hazard ratio, OS Overall survival, PFS Progression-free survival
  2. P < 0.05 was considered statistically significant